452
Participants
Start Date
August 31, 2000
Primary Completion Date
January 31, 2003
Study Completion Date
December 31, 2007
ARIMIDEX (anastrazole)
NOLVADEX (tamoxifen)
Research Site, Santa Rosa
Research Site, New Britain
Research Site, Torrington
Research Site, Springfield
Research Site, Mason City
Research Site, Baton Rouge
Research Site, Pittsfield
Research Site, St Louis
Research Site, Albuquerque
Research Site, Portland
Research Site, Austin
Research Site, Houston
Research Site, Olympia
Research Site, Antwerp
Research Site, Hasselt
Research Site, Leuven
Research Site, Liège
Research Site, Rio de Janeiro
Research Site, Porto Alegre
Research Site, São Paulo
Research Site, Fortaleza
Research Site, Porto Alegre
Research Site, Sheffield
Research Site, Edmonton
Research Site, Newmarket
Research Site, Chicoutimi
Research Site, Montreal
Research Site, Québec
Research Site, Brno
Research Site, Nová Ves pod Pleší
Research Site, Olomouc
Research Site, Peské Budjovice
Research Site, Prague
Research Site, Praha-5
Research Site, Lyon
Research Site, Avignon
Research Site, Dijon
Research Site, Limoges
Research Site, Lyon
Research Site, Marseille
Research Site, Montpellier
Research Site, Nice
Research Site, Paris
Research Site, Tours
Research Site, Budapest
Research Site, Győr
Research Site, Kecskemét
Research Site, Szeged
Research Site, Szolnok
Research Site, Bologna
Research Site, Cagliari
Research Site, Monserrato
Research Site, Kashiwa
Research Site, Florence
Research Site, Genova
Research Site, Palermo
Research Site, Reggio Emilia
Research Site, Nagoya
Research Site, Chiba
Research Site, Matsuyama
Research Site, Fukuoka
Research Site, Kitakyushu
Research Site, Ōta
Research Site, Fukuyama
Research Site, Sapporo
Research Site, Amagasaki
Research Site, Isehara
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Niigata
Research Site, Ōita
Research Site, Osaka
Research Site, Sayama
Research Site, Suita
Research Site, Kitaadachi
Research Site, Chūō
Research Site, Nijmegen
Research Site, Sittard
Research Site, The Hague
Lead Sponsor
AstraZeneca
INDUSTRY